Organoid Cultures Derived from Patients with Advanced Prostate Cancer
s
citsiretcarahCdionagrOdnatneitaP.1elbaT2Cell159,1–12,September25,2014ª2014Elsevier

Inc.
etal.,1999).Recentadvancesingenomicstechnologyhavegeneratedacatalogofgeneticlesionsthatunderlieprostatetumorigenesis(Bacaetal.,2013;Barbierietal.,2012;Tayloretal.,2010),manyofwhich(e.g.,SPOPmutation,FOXA1muta-tion,CHD1loss)arenotrepresentedinavailablecelllines.Furthermore,incastration-resistantprostatecancer(CRPC),wheretheimmenseselectionpressureoftherapycanleadtosigni cantlyincreasedheterogeneity(Grassoetal.,2012),alargerepositoryofCRPClineswouldberequiredtorepresentdifferentmechanismsofresistance.
Wesoughttogenerateinvitromodelsofprostatecancerderivedfromcontemporarypatientsthatrepresentthespectrumofthoseundergoingtreatmentforthedisease.Wehavede nedgrowthconditionsforsmallintestine,largeintestine,pancreas,andliver,wheresingleepithelialstemcellsformorganoidsthatrecapitulatethetissuehistologyandlineagehierarchyinvitro(Barkeretal.,2010;Huchetal.,2013a;Huchetal.,2013b;Satoetal.,2009).Intheaccompanymanuscript(Karthausetal.,2014,thisissue),wedevelopedconditionsoptimizedforcontin-uouspropagationofbothnormalhumanbasalandluminalpros-tateepithelialcells.Usingtheseprostatespeci cconditions,wereportsuccessinthegenerationanddetailedmolecularcharac-terizationofsevenhuman-derivedprostatecancerorganoidlinesderivedfromdiversediseasesitesincludingcirculatingtumorcells.Theselinesharborcopynumbersignaturesofprimarypros-tatecancer,includingSPOPmutation,PTENloss,TMPRSS2-ERGinterstitialdeletion,aswellasalterationscommonlyfoundinCRPCincludingTP53,PIK3R1,FOXA1,andseveralchromatinmodi ermutations.Further,theorganoidlinesrecapitulatethephenotypicdiversityofCRPC,includingAR-dependentadeno-carcinoma,AR-negativeadenocarcinoma,neuroendocrinecar-cinoma,andsquamousdifferentiation.Importantly,theselinesareamenabletodrugtestinginvitroandinvivo.RESULTS
Weplatedprostatecancermetastasissamples,freshlycollectedbytissuebiopsyandcon rmedbypathologyreviewtohave>10%tumorcellcontent,intoprostateorganoidcultureandes-tablishedorganoidlinesfromsixpatientsthathavebeencontin-uouslypropagatedfor>6months.Aseventhorganoidlinewasestablishedfromcirculatingtumorcells(CTCs)ofaCRPCpa-tientwithahighCTCcount(>100cellsper8mlofblood).Theclinicalcharacteristicsandprognosticvariables(Smaletzetal.,2002)ofthesevenpatientsspanthespectrumofadvancedpros-tatecancer(Table1).
Inourhands,theef ciencyforestablishingcontinuouslyprop-agatedorganoidlinesfrommetastaticbiopsieswas 15%–20%(6linesfrom32‘‘attempts’’ofcancer-bearingsamples)andcouldpresumablybeimprovedbyfurtheroptimizationofgrowthconditions.Itisworthnotingthattumororganoidswererepro-duciblymaintainedfor1–2monthsfor 70%ofsofttissuetumorbiopsiesand 30%ofbonebiopsybiopsies,butmanyofthesetumorcultureswereovertakenbytumor-associatedspindlecellsornormalepithelialcellspresentinthebiopsymaterial.Forexample,twocontinuouslyproliferatingorganoidlinesderivedfromliverandlungmetastaseshadnocopynumberalterationsandnomutationsof50commoncancer-associatedgenes

(not
from patients with advanced prostate, bladder, or breast cancer as well as...Regardless of whether the peptidome is derived from the tissue/microenvironment...
[6], advanced melanoma [11], prostate cancer [...from healthy donors and from patients with chronic...In DC cultures of four healthy donors, Freezing ...
热门文档